We are excited to announce that we will attend the 2025 SNMMI Annual Meeting, the premier educational, scientific, research, and networking event in nuclear medicine and molecular imaging.

The development of radiopharmaceutical solutions, whether for diagnostics or therapeutics, is full of challenges. Companies must navigate diverse regulatory landscapes, a complex payer environment with high prices and cost pressures, and varying levels of nuclear medicine maturity across geographies.

Our team can accompany you on this complex development journey. We understand each step; from choosing the relevant regulatory pathway to delineating the reimbursement landscape and determining optimal clinical and competitive positioning of your product.